Pulmonary Embolism After Coronary Artery Bypass Grafting
2004; Lippincott Williams & Wilkins; Volume: 109; Issue: 22 Linguagem: Inglês
10.1161/01.cir.0000132616.89315.34
ISSN1524-4539
AutoresSamuel Z. Goldhaber, U. Joseph Schoepf,
Tópico(s)Acute Myocardial Infarction Research
ResumoHomeCirculationVol. 109, No. 22Pulmonary Embolism After Coronary Artery Bypass Grafting Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBPulmonary Embolism After Coronary Artery Bypass Grafting Samuel Z. Goldhaber, MD and U. Joseph Schoepf, MD Samuel Z. GoldhaberSamuel Z. Goldhaber From the Cardiovascular Division, Department of Medicine (S.Z.G.), and the Department of Radiology (U.J.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. and U. Joseph SchoepfU. Joseph Schoepf From the Cardiovascular Division, Department of Medicine (S.Z.G.), and the Department of Radiology (U.J.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Originally published8 Jun 2004https://doi.org/10.1161/01.CIR.0000132616.89315.34Circulation. 2004;109:2712–2715Case Presentation: A 76-year-old man developed increased fatigue during his daily 40-lap swim and daily 3-mile walk. His past medical history included use of hydrochlorothiazide for hypertension. His physical examination and baseline ECG were normal. An exercise treadmill test demonstrated ischemia, and cardiac catheterization showed left main and 3-vessel obstructive coronary artery disease. Echocardiography revealed normal left ventricular function.He underwent a 3-vessel coronary artery bypass grafting (CABG) with the left internal mammary artery grafted to the left anterior descending, and separate saphenous vein grafts, harvested endoscopically from the left leg, to the obtuse marginal branch and posterior descending coronary artery. The surgery was uncomplicated, with an aortic cross clamp time of 73 minutes and cardiopulmonary bypass time of 89 minutes.On the first postoperative day, he was transferred out of the intensive care unit. By the fifth postoperative day, he was walking 100 feet steadily without use of any assist device. He was discharged home on the sixth postoperative day on enteric-coated aspirin, hydrochlorothiazide, metoprolol, and atorvastatin.He presented to his community hospital on the 30th postoperative day, complaining of 5 days of increasing fatigue and 1 day of markedly increased shortness of breath. The ECG showed a heart rate of 79 beats per minute and nonspecific ST and T wave abnormalities. The D-dimer level was elevated (>8000 ng/mL). Contrast-enhanced spiral computed tomography (CT) of the pulmonary arteries, including additional sections of the lower extremities, acquired during venous phase of contrast enhancement ("indirect CT venography") showed a large bilateral central pulmonary embolism (PE) and a right leg deep vein thrombosis (DVT), without DVT in the leg from which the saphenous vein had been harvested (Figure 1). He was transferred to Brigham and Women's Hospital for further management, where he was hospitalized for 6 days, received enoxaparin as a "bridge" to warfarin, and was discharged uneventfully. Download figureDownload PowerPointFigure 1. A, Contrast-enhanced transaxial spiral computed tomographic scan at the level of the bifurcation of the main pulmonary artery (PA). Scan acquired during the pulmonary arterial phase of contrast enhancement. Hypodense (dark) filling defects (open arrows) are visualized in the left (L) and right (R) main pulmonary artery, which represent clots secondary to acute pulmonary embolism. Note hyperdense (white) appearing calcified granuloma (arrow) close to the dorsal pleura of the left lung as an incidental finding. B, Contrast-enhanced transaxial spiral computed tomographic scans obtained at the level of the hip-joint. Scan acquired during the systemic venous phase of contrast enhancement, after acquisition of the pulmonary arterial system (indirect CT venography). A hypodense (dark) filling defect (arrow) is visualized within the contrast enhanced lumen of the right (R) femoral vein, which represents residual deep venous thrombosis in the non graft-harvest (right) leg. Note normal appearance of veins in the contralateral harvest (left, L) leg, without thrombotic filling defects. Note hyperdense (white) appearing calcifications of the prostate gland (P) as an incidental finding.DiscussionChallenges in Prediction and Detection of PE After CABGAsymptomatic venous thromboembolism (VTE) occurs after CABG with surprisingly high frequency. Though not clinically important in most instances, it serves as a harbinger for massive symptomatic DVT and PE, including life threatening and fatal events. Unfortunately, there is no foolproof way of determining who will develop VTE or who will suffer a rare but deadly complication. The patient who we present deceptively appeared to be at low risk of postoperative PE because he had only mild hypertension as a comorbidity and was in excellent physical shape. He illustrates the teaching point that predicting who will have a PE is difficult and, therefore, universal measures to prevent postoperative VTE are of paramount importance.The low detection rate of symptomatic VTE after CABG is understandable. Shortness of breath is often ascribed to deconditioning, atelectasis, or preexisting left ventricular dysfunction. The patient who we discuss had a normal heart rate, normal blood pressure, normal ECG, and vague symptoms. His presentation could have been ascribed to pericarditis, costochondritis, or anxiety. Undoubtedly, some of the patients who "die suddenly" within 30 days of CABG succumb to PE without any clear warning signs and without the diagnosis of PE being established. DVT is also difficult to detect clinically because leg discomfort and swelling may be attributed to trauma from the vein harvest site, excessive hydration during cardiopulmonary bypass, or muscle cramping due to perioperative immobility. Rarely is DVT suspected in the contralateral leg after vein harvest for CABG.Scope of the ProblemAt Brigham and Women's Hospital, we performed predischarge venous ultrasonography in 330 patients who had undergone CABG.1 Overall, 67 (20%) had DVT diagnosed by ultrasonography. Clots were found as often in the leg contralateral to the saphenous vein graft harvest site as in the ipsilateral leg. Of those with DVT, 56 (84%) had thrombi isolated to the calf, and 11 (16%) had DVT in proximal leg veins. Two patients had symptomatic PE, including a 51-year-old man who died from massive PE despite emergent pulmonary embolectomy. Only 1 patient had symptomatic DVT, which was proximal. Thus, the ratio of isolated calf DVT to proximal leg DVT was approximately 5–to–1, and the ratio of all DVT to symptomatic PE or DVT exceeded 20–to–1. These findings indicate that almost all DVT after CABG is asymptomatic and most often is confined to the calf veins. However, we found that although symptomatic VTE occurred in only about 1% of CABG patients, it can result in fatal PE.Our observations at Brigham and Women's Hospital are consistent with those of the California Patient Discharge Data Set, in which 66 180 records were surveyed for symptomatic VTE within 91 days after CABG.2 Overall, 736 patients (1.1%; 95% confidence interval 1.1 to 1.2) were detected with symptomatic DVT or PE. Two thirds (0.7%) were diagnosed after hospital discharge.If we extrapolate these findings to the entire United States, based on 500 000 CABG operations annually, then each year, approximately 100 000 patients develop DVT, with about 84 000 isolated to the calf and 16 000 with proximal disease. Only about 10 000 have disease that is symptomatic and diagnosed definitively. Because of short hospitalizations, about 7000 of the diagnosed cases are recognized after hospital discharge. Assuming a mortality rate of 1% among asymptomatic patients and 2% to 4% among symptomatic patients with overt DVT and PE, there are between 1100 and 1300 potentially preventable postoperative deaths each year in the United States alone, including patients who die from PE in which the death is ascribed to other etiologies, such as arrhythmia or myocardial infarction.In addition to death from PE and disability from chronic thromboembolic pulmonary hypertension, VTE increases health care costs because it contributes to hospital readmissions after CABG. In New York State in 1999, 16 325 patients were discharged after CABG, and 2111 (12.9% of live discharges) were readmitted within 30 days for complications directly related to CABG.3 PE and DVT constituted the fifth most common cause of readmission, 6.3% of all readmissions, and were exceeded in frequency only by infections, heart failure, myocardial ischemia, and arrhythmia. The median length of time until readmission was 9 days, with an interquartile range of 4 to 17 days.Rationale for Universal ProphylaxisPE and DVT are easier and less expensive to prevent than to diagnose or treat. Therefore, virtually all CABG patients should receive prophylactic measures against VTE. CABG is particularly well suited for protocols that proactively prevent anticipated potential complications. However, primary prevention of perioperative VTE with standard mechanical or pharmacological prophylactic measures4,5 is often not routine practice.In a registry of 5451 US patients with ultrasound-confirmed DVT, only 42% of the inpatients had received prophylaxis within 30 days before diagnosis.6Various theses are proposed to justify omission of specific VTE prophylaxis protocols after CABG. Administration of tens of thousands of units of heparin during cardiopulmonary bypass has traditionally been considered protective, though an increasing proportion of patients are undergoing off-pump CABG. Aspirin, used universally after CABG, may have a very weak but measurable effect in reducing the frequency of postoperative VTE.7 Thus, the use of aspirin is at times claimed to be sufficient for prevention of VTE after CABG. Early ambulation and routine hospital discharge within 4 to 5 days minimize the period of immobility and lower the risk of DVT or PE. However, hospitalized patients may be much more mobile when prodded by nurses and physical therapists than they are after discharge home.Strategies to Prevent PE After CABGTo prevent VTE after CABG, cardiac surgeons can utilize mechanical prophylaxis, pharmacological prophylaxis, or a combination of both strategies.8 Most concerning to the cardiac surgeon is the possibility of doing harm with pharmacological prophylaxis. Bleeding complications are immediately apparent, but PEs prevented by heparin remain invisible. Routine heparin injections increase the pharmacy expenditures and are perceived as an additional annoyance or minor discomfort by some patients.The two principal mechanical prophylaxis measures are graduated compression stockings (GCS) and intermittent pneumatic compression (IPC) devices. GCS increase venous blood flow and prevent perioperative venodilation of the legs. They are inexpensive, simple, and free of serious complications such as hemorrhage. In randomized trials evaluating GCS for VTE prevention after non-orthopedic surgery, there was an overall reduction of 72% in DVT.9IPC devices ("pneumoboots") provide intermittent inflation of air-filled cuffs, prevent venous stasis in the legs, and compress the veins more forcefully than GCS; they also stimulate the endogenous fibrinolytic system.10 Their main drawback is lack of use due to poor patient compliance, especially after transfer out of the intensive care unit.Subcutaneous administration of fixed-dose unfractionated or low molecular weight heparin helps prevent perioperative VTE. The most comprehensive randomized, controlled trial of low-dose unfractionated heparin ("mini-dose heparin") as prophylaxis against fatal postoperative PE was performed in the pre-CABG era, enrolled 4121 patients, and was published in 1975 as the International Multicenter Trial.11 Prophylaxis consisted of 5000 U of heparin administered subcutaneously, 2 hours preoperatively and every 8 hours thereafter for 7 days. Eligible patients were over age 40 and were scheduled to undergo elective major surgery. Sixteen patients in the control group versus 2 in the heparin group died of PE confirmed by autopsy.Collins and colleagues12 pooled the data from 78 randomized controlled mini-dose heparin trials with 15 598 surgical patients. There was a 40% reduction in nonfatal PE and 64% reduction in fatal PE among patients treated prophylactically with heparin 5000 U every 8 to 12 hours. Patients assigned to heparin had about one-third as many DVTs as control patients, regardless of whether they had undergone general, urological, elective orthopedic, or trauma surgery. Overall, there was a 2% increase in the rate of excessive bleeding, especially common after urological procedures.Low molecular weight heparins have several advantages over unfractionated heparin,13 but they have not been tested extensively in CABG patients. Low molecular weight heparins exhibit less binding to plasma proteins and to endothelial cells than unfractionated heparin. Consequently, they tend to have a more predictable dose response, a more dose-independent mechanism of clearance, and a longer plasma half-life than unfractionated heparin. Furthermore, osteoporosis and heparin-induced thrombocytopenia seem to be less common with low molecular weight heparins than with unfractionated heparin. In most prevention trials, low molecular weight heparins are administered as once daily subcutaneous injections in low, fixed doses, without laboratory monitoring or dose adjustment.What is a practical approach to preventing PE after CABG (Figure 2)? Both GCS and IPC devices can be used immediately postoperatively in the leg contralateral to the saphenous vein harvest. GCS reduces the frequency of venous thrombosis and should therefore be considered first-line prophylaxis against PE, except for those with peripheral arterial occlusive disease whose condition may be worsened by vascular compression. IPC devices are most effective in the intensive care unit, where compliance can readily be monitored and enforced. Download figureDownload PowerPointFigure 2. Proposed protocol for preventing PE after CABG. BID incidates twice daily; TID, thrice daily.Pharmacological prophylaxis should be considered as a routine prevention measure after CABG. The strategy least likely to cause excessive bleeding is administration of 5000 U of unfractionated heparin subcutaneously twice daily. Patients with additional VTE risk factors are candidates for more intensive prophylaxis, either with heparin 5000 U three times daily, enoxaparin 40 mg once daily, or dalteparin 5000 U once daily.Future PerspectivesFuture clinical trials should investigate VTE prophylaxis among patients undergoing CABG. In addition to unfractionated heparin and low molecular weight heparin, novel anticoagulants such as fondaparinux,14 a direct factor Xa inhibitor, and ximelagatran,15 an oral direct thrombin inhibitor, appear promising for the prevention of VTE and should be studied in patients undergoing CABG. Finally, computer-generated prompting may increase the utilization of prophylaxis orders.16 The results of these trials will contribute to continuous quality improvement.17FootnotesCorrespondence to Samuel Z. Goldhaber, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115. E-mail [email protected] References 1 Goldhaber SZ, Hirsch DR, MacDougall RC, et al. Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies). Am J Cardiol. 1995; 76: 993–996.CrossrefMedlineGoogle Scholar2 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003; 90: 446–455.CrossrefMedlineGoogle Scholar3 Hannan EL, Racz MJ, Walford G, et al. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA. 2003; 290: 773–780.CrossrefMedlineGoogle Scholar4 Prevention of venous thromboembolism: International Consensus Statement Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001; 20: 1–37.MedlineGoogle Scholar5 Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001; 119 (1 suppl): 132S–175S.CrossrefMedlineGoogle Scholar6 Goldhaber SZ, Tapson VF, for the DVT FREE Steering Committee. A prospective registry of 5451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004; 93: 67–70.Google Scholar7 Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324: 71–86.CrossrefMedlineGoogle Scholar8 Ramos R, Salem BI, De Pawlikowski MP, et al. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest. 1996; 109: 82–85.CrossrefMedlineGoogle Scholar9 Wells PS, Lensing AWA, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med. 1994; 154: 67–72.CrossrefMedlineGoogle Scholar10 Kessler CM, Hirsch DR, Jacobs H, et al. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolys. 1996; 7: 437–446.CrossrefMedlineGoogle Scholar11 Prevention of fatal postoperative pulmonary embolism by low doses of heparin: an international multicentre trial. Lancet. 1975; 2: 45–51.MedlineGoogle Scholar12 Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988; 318: 1162–1173.CrossrefMedlineGoogle Scholar13 Hirsh J, Anand SS, Halperin JL, et al. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation. 2001; 103: 2994–3018.CrossrefMedlineGoogle Scholar14 Bounameaux H, Perneger T. Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention. Lancet. 2002; 359: 1710–1711.CrossrefMedlineGoogle Scholar15 Francis CW, Berkowitz SD, Comp PC, et al. EXULT A Study Group. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003; 349: 1703–1712.CrossrefMedlineGoogle Scholar16 Durieux P, Nizard R, Ravaud P, et al. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA. 2000; 283: 2816–2821.CrossrefMedlineGoogle Scholar17 Ferguson TB Jr, Peterson ED, Coombs LP, et al. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. JAMA. 2003; 290: 49–56.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Aquino T, Faria Rosseto S, Lúcio Vaz J, Faria Cordeiro Alves C, Vidigal F and Galdino G (2021) Evaluation of respiratory and peripheral muscle training in individuals undergoing myocardial revascularization, Journal of Cardiac Surgery, 10.1111/jocs.15698, 36:9, (3166-3173), Online publication date: 1-Sep-2021. (2021) Post‐ICU Care and Other Complications Manual of Perioperative Care in Adult Cardiac Surgery, 10.1002/9781119582540.ch13, (737-842), Online publication date: 8-Jan-2021. Klingele M, Enkel J, Speer T, Bomberg H, Baerens L and Schäfers H (2020) Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting, Journal of Cardiothoracic Surgery, 10.1186/s13019-020-1059-8, 15:1, Online publication date: 1-Dec-2020. Panhwar M, Ginwalla M, Kalra A, Gupta T, Kolte D, Khera S, Bhatt D and Sabik J (2019) Association of Acute Venous Thromboembolism With In‐Hospital Outcomes of Coronary Artery Bypass Graft Surgery, Journal of the American Heart Association, 8:19, Online publication date: 1-Oct-2019. Mathew S, Beavers C and McNeely E (2016) The National Practice Patterns of Venous Thromboembolism Prophylaxis Post-Cardiothoracic Surgery, Journal of Pharmacy Practice, 10.1177/0897190016645035, 30:4, (394-399), Online publication date: 1-Aug-2017. Viana V, Melo E, Terra-Filho M, Dallan L, Gonzalez M, Hajjar L, Jatene F, Cesar L and Vianna C (2017) Frequency of Deep Vein Thrombosis and/or Pulmonary Embolism After Coronary Artery Bypass Grafting Investigation Regardless of Clinical Suspicion, The American Journal of Cardiology, 10.1016/j.amjcard.2016.09.056, 119:2, (237-242), Online publication date: 1-Jan-2017. Zuin M, Rigatelli G, Faggian G, Zonzin P and Roncon L (2016) Short-term outcome of patients with history of significant coronary artery disease following acute pulmonary embolism, European Journal of Internal Medicine, 10.1016/j.ejim.2016.05.015, 34, (e16-e17), Online publication date: 1-Oct-2016. Lüders F and Reinecke H (2015) Gefäßerkrankungen und -komplikationen im Rahmen von HerzoperationenVascular diseases and complications in cardiac surgery, Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 10.1007/s00398-015-0006-9, 29:3, (201-212), Online publication date: 1-Jun-2015. Stephens R and Whitman G (2015) Postoperative Critical Care of the Adult Cardiac Surgical Patient, Critical Care Medicine, 10.1097/CCM.0000000000001171, 43:9, (1995-2014), Online publication date: 1-Sep-2015. Taniguchi T, Kato M, Ueda S, Yokomatsu T, Mizoguchi T, Miki S and Yoshida A (2015) Prevalence and Significance of Clinically Unsuspected Pulmonary Embolism: Detection Using Coronary Computed Tomography Angiography, Journal of Cardiac Surgery, 10.1111/jocs.12512, 30:4, (301-306), Online publication date: 1-Apr-2015. Kulik A, Rassen J, Myers J, Schneeweiss S, Gagne J, Polinski J, Liu J, Fischer M and Choudhry N (2012) Comparative Effectiveness of Preventative Therapy for Venous Thromboembolism After Coronary Artery Bypass Graft Surgery, Circulation: Cardiovascular Interventions, 5:4, (590-596), Online publication date: 1-Aug-2012. Lee C, Kim Y, Shim D, Na C and Oh S (2011) The detection of pulmonary embolisms after a coronary artery bypass graft surgery by the use of 64-slice multidetector CT, The International Journal of Cardiovascular Imaging, 10.1007/s10554-011-9868-4, 27:5, (639-645), Online publication date: 1-Jun-2011. Protopapas A, Baig K, Mukherjee D and Athanasiou T (2011) Pulmonary Embolism Following Coronary Artery Bypass Grafting, Journal of Cardiac Surgery, 10.1111/j.1540-8191.2010.01195.x, 26:2, (181-188), Online publication date: 1-Mar-2011. Dávid M, Losonczy H, Udvardy M, Boda Z, Blaskó G, Tar A and Pfliegler G Risk assessment model for venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian Antithrombotic Guidelines entitled "Diminution and Treatment of Venous Thromboembolism", Orvosi Hetilap, 10.1556/oh.2010.28944, 151:34, (1365-1374) Kalavrouziotis D, Legare J, Baskett R, Dickieson A, Ali I, Ali I and Rapchuk I (2010) A Case of Massive Pulmonary Embolism After Cardiac Surgery: The Role of Epicardial Echocardiography, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2009.02.004, 24:2, (309-311), Online publication date: 1-Apr-2010. (2010) Post-ICU Care and Other Complications Manual of Perioperative Care in Adult Cardiac Surgery, 10.1002/9781444325287.ch13, (641-725) Geerts W, Bergqvist D, Pineo G, Heit J, Samama C, Lassen M and Colwell C (2008) Prevention of Venous Thromboembolism, Chest, 10.1378/chest.08-0656, 133:6, (381S-453S), Online publication date: 1-Jun-2008. Kuklinski D, Tevaearai H, Eckstein F and Carrel T (2019) Acute Pulmonary Embolectomy Three Days following a Coronary Artery Bypass Graft Procedure, Anaesthesia and Intensive Care, 10.1177/0310057X0703500224, 35:2, (294-297), Online publication date: 1-Apr-2007. Gutierrez G and Jain V (2006) Medical Issues in Patients With Cardiothoracic Surgery, Clinical Pulmonary Medicine, 10.1097/01.cpm.0000220467.51134.90, 13:3, (178-187), Online publication date: 1-May-2006. AMBROSETTI M, AGENO W, SALERNO M and PEDRETTI R (2005) Postoperative pericardial effusion in patients receiving anticoagulants for deep vein thrombosis after coronary artery bypass graft surgery, Journal of Thrombosis and Haemostasis, 10.1111/j.1538-7836.2005.01575.x, 3:10, (2367-2368) Juratli M, Menyaev Y, Sarimollaoglu M, Siegel E, Nedosekin D, Suen J, Melerzanov A, Juratli T, Galanzha E, Zharov V and Aboussekhra A (2016) Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry, PLOS ONE, 10.1371/journal.pone.0156269, 11:5, (e0156269) FG N (2014) The Application of Extracorporeal Membrane Oxygenation in Surgical Pulmonary Embolectomy, Journal of Cardiology & Current Research, 10.15406/jccr.2014.01.00016, 1:3 June 8, 2004Vol 109, Issue 22 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000132616.89315.34PMID: 15184296 Originally publishedJune 8, 2004 PDF download Advertisement
Referência(s)